Guide · Updated November 2026
GLP-1 and Gut Health: What Happens to Your Microbiome
GLP-1 drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) slow how fast your stomach empties, and stomach and bowel side effects are the most common ones on their labels. Research on what they do to the gut microbiome is early. A 2025 systematic review found 38 studies, most of them in animals, with mixed results that differ by drug. There is not yet solid human evidence that these drugs reshape your gut bacteria in a predictable way.
Your body carries roughly 38 trillion bacteria, about the same number as your own human cells. When you start a GLP-1, you change your appetite, how much you eat, and how fast food moves. That changes the environment those bacteria live in, even if researchers have not yet mapped exactly how.
I have been on Mounjaro for over a year now, and the gut changes were some of the first things I noticed. Not just the nausea everyone talks about, but subtler shifts: different digestion patterns, changes in what foods I could tolerate, even differences in bloating.
How GLP-1 Medications Change Your Digestive System
GLP-1 receptor agonists mimic a hormone called glucagon-like peptide-1 that your gut already releases after meals. The medications make that signal much stronger and longer lasting.
Slower stomach emptying. Both the Wegovy and Zepbound labels describe delayed gastric emptying. This is part of why you feel full after a small meal. The labels also warn about severe stomach and bowel side effects and say these drugs are not recommended for people with severe gastroparesis.
Eating less, and eating differently. Lower appetite means less food and often less fiber reaching your gut bacteria, which feed on what you eat.
These changes are real, but how much they change the bacteria themselves is still an open question in human research.
What the Research Shows About GLP-1 and the Microbiome
The honest summary is that the evidence is thin.
A 2025 systematic review in Nutrients gathered 38 studies on GLP-1 drugs and gut bacteria in animals and humans. The authors found that liraglutide promoted the growth of bacteria linked to better metabolism. Dulaglutide was linked to increases in Bacteroides, Akkermansia, and Ruminococcus. Exenatide gave mixed results, and in human studies it raised both groups linked to better metabolism and groups linked to inflammation. Most of the included studies were in animals, and human data for semaglutide and tirzepatide were limited.
You may see claims online that semaglutide or tirzepatide raise Akkermansia by a set percentage, or that they improve your Firmicutes-to-Bacteroidetes ratio. We could not find human trials that support specific numbers like these, so we removed them from this page.
The other open question is whether any microbiome changes come from the drug itself or from eating less and losing weight. Human studies have not settled that.
The GI Side Effects Connection
Stomach and bowel side effects are the most common reactions in the FDA labels. In the pooled weight-loss trials:
| Side effect | Wegovy 2.4 mg vs placebo | Zepbound 5, 10, 15 mg vs placebo |
|---|---|---|
| Nausea | 44% vs 16% | 25%, 29%, 28% vs 8% |
| Diarrhea | 30% vs 16% | 19%, 21%, 23% vs 8% |
| Vomiting | 24% vs 6% | 8%, 11%, 13% vs 2% |
| Constipation | 24% vs 11% | 17%, 14%, 11% vs 5% |
These figures come from separate trials with different people, so they are not a head-to-head comparison of the two drugs.
Slower stomach emptying and big changes in what you eat are the most direct explanations for these symptoms. Whether shifts in gut bacteria also play a part is not established. In trials, GI side effects were most common during dose increases. The SURMOUNT-5 trial reported that most GI events with both tirzepatide and semaglutide were mild to moderate and happened mainly during dose escalation.
I noticed this pattern on Mounjaro. The first two weeks at each new dose brought more bloating and irregular digestion. By week three or four, things settled. That is my experience, not a finding from research.
Compare GLP-1 providers
Browse Provider Directory →What This Means for Weight Loss
Some researchers think gut bacteria could play a part in how well GLP-1 drugs work. That idea is not proven in people. The main driver of weight loss on these drugs is eating less because of lower appetite and slower digestion.
In SURMOUNT-5 (NEJM, 2025), tirzepatide produced 20.2% mean weight loss at 72 weeks versus 13.7% for semaglutide. There is no evidence yet that microbiome differences explain that gap.
On body composition, the SURMOUNT-1 DEXA substudy found fat mass fell 33.9% and lean mass fell 10.9% on tirzepatide. See our body composition guide for more.
Should You Take Probiotics on a GLP-1?
This is one of the most common questions I see in GLP-1 forums, and the honest answer is that we do not have good data.
What we know:
- No clinical trial we found has tested probiotics alongside GLP-1 medications for weight loss.
- In other settings, some probiotic strains have been studied for bloating and diarrhea, with mixed results.
- A 2018 study in Cell found that a multi-strain probiotic given after antibiotics delayed the return of people’s and mice’s own gut bacteria compared with no treatment. That was an antibiotic study, not a GLP-1 study, but it shows probiotics are not automatically helpful.
What I do personally: I focus on fiber-rich foods rather than probiotic supplements. Things like onions, garlic, asparagus, oats, and beans. If you want to try a probiotic, talk to your prescriber or pharmacist first, especially if you have a weakened immune system. I cover more on supplements in the best supplements on GLP-1s guide.
Practical Steps to Support Your Gut on GLP-1s
1. Add Fiber Slowly
Fiber feeds gut bacteria and helps with constipation. Fiber plus slower digestion can mean bloating if you add too much at once, so increase it gradually. Soluble fiber (oats, beans, sweet potatoes) is often easier to tolerate than rough insoluble fiber.
2. Stay Hydrated
Constipation is common on these drugs, and dehydration makes it worse. Vomiting and diarrhea can also dehydrate you, and both the Wegovy and Zepbound labels warn about kidney injury from dehydration. Ask your prescriber how much fluid is right for you, especially if you have kidney or heart problems.
3. Include Fermented Foods if You Tolerate Them
Yogurt, kefir, kimchi, and sauerkraut are normal foods that contain live bacteria. They are a reasonable part of a varied diet. There is no GLP-1-specific evidence on how much helps.
4. Get Enough Protein
Lower appetite can make it hard to eat enough protein, which matters for keeping muscle. Ask your prescriber or a dietitian for a target that fits you. See protein intake on GLP-1s and fat loss vs weight loss.
5. Watch for Warning Signs
Most GI changes on GLP-1s are mild and settle with time. Call your prescriber or get urgent care for:
- Severe stomach pain that doesn’t go away, with or without vomiting, which can be a sign of pancreatitis
- Pain in the upper right abdomen, fever, or yellowing of your skin or eyes, which can point to gallbladder problems
- Vomiting or diarrhea that keeps you from keeping fluids down
- Blood in your stool
- Constipation that doesn’t improve, or severe bloating
Don’t stop or change your dose on your own. Your prescriber may adjust your dose schedule if side effects are hard to manage.
GLP-1 Gut Effects by Medication
| Factor | Semaglutide (Ozempic/Wegovy) | Tirzepatide (Mounjaro/Zepbound) |
|---|---|---|
| Nausea (label, weight-loss trials) | 44% (Wegovy 2.4 mg) | 25% to 29% (Zepbound) |
| Constipation | 24% | 11% to 17% |
| Diarrhea | 30% | 19% to 23% |
| Human microbiome data | Limited | Limited |
| Mechanism | GLP-1 receptor agonist | GLP-1 and GIP receptor agonist |
Lower label rates for tirzepatide do not prove it is easier on the gut, since the trials were different. Some people who struggle on Ozempic do better after switching to Mounjaro, and some do not. That switch is a decision for your prescriber.
Pipeline drugs add more questions. Retatrutide, Lilly’s triple agonist (GLP-1, GIP, and glucagon), showed 24.2% weight loss at 48 weeks in its phase 2 trial. Lilly reported 28.7% weight loss at 68 weeks with the 12 mg dose in the phase 3 TRIUMPH-4 trial. Its effects on gut bacteria have not been studied in people.
The Bottom Line
GLP-1 medications change how you digest food, and stomach and bowel side effects are their most common side effects. What they do to your gut bacteria is still unclear. Most microbiome research so far is in animals, and the results are mixed. Focus on what helps your symptoms: add fiber slowly, stay hydrated, eat regular meals with protein, and tell your prescriber about side effects that don’t settle. If you are comparing providers to start treatment, see the provider directory.
FAQ
Does Ozempic kill gut bacteria?
There is no evidence that semaglutide kills gut bacteria. It slows digestion and lowers how much you eat, which can change the gut environment. Human data on what that does to specific bacteria are limited.
Should I take probiotics while on Mounjaro or Ozempic?
There is no clinical trial data on probiotics alongside GLP-1 medications. Fiber-rich foods are a reasonable first step. If you want to try a probiotic, ask your prescriber or pharmacist first.
How long do gut changes last on GLP-1 medications?
In trials, stomach and bowel side effects were most common during dose increases and often eased over time. How long any microbiome changes last, including after stopping the drug, has not been well studied in people.
Why does constipation happen on GLP-1 doses?
Slower digestion and eating less food and fiber both play a part. Constipation was reported in 24% of adults on Wegovy 2.4 mg and 11% to 17% on Zepbound in the label trials. Fiber, fluids, and activity can help. Ask your prescriber before using a laxative or supplement. See our constipation guide.
Can GLP-1 medications cause SIBO (small intestinal bacterial overgrowth)?
We found no good data showing GLP-1 drugs cause SIBO. If you have persistent bloating, gas, or abdominal discomfort that gets worse rather than better, talk to your doctor about what could be causing it.
Related
Guides:
- Side Effects Guide · Constipation · Gallbladder Problems
- Best Supplements on GLP-1 · Protein Intake · Body Composition Guide
Provider Reviews: Ro · Hims · MEDVi
Compare: All Providers · Best GLP-1 Programs · All Guides
What we checked
This AI-assisted public-source desk check reviewed the Wegovy and Zepbound FDA labels on DailyMed, a 2025 systematic review of GLP-1 drugs and gut bacteria, the SURMOUNT-5 and SURMOUNT-1 body composition papers, a 2018 Cell probiotics study, a PLoS Biology estimate of bacterial cell counts, and retatrutide trial results from PubMed and Lilly on November 4, 2026. This is not a clinical review and it is not medical advice. Prices and policies change, so confirm them with the provider or your prescriber before you act.